Drug Shortage Report for PREGABALIN
Report ID | 143962 |
Drug Identification Number | 02403692 |
Brand name | PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 25MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-08-30 |
Actual start date | |
Estimated end date | 2021-09-20 |
Actual end date | 2021-10-01 |
Shortage status | Resolved |
Updated date | 2021-10-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-08-11 | English | Compare |
v2 | 2021-08-11 | French | Compare |
v3 | 2021-08-17 | English | Compare |
v4 | 2021-08-17 | French | Compare |
v5 | 2021-08-31 | English | Compare |
v6 | 2021-10-19 | English | Compare |
v7 | 2021-10-19 | French | Compare |
Showing 1 to 7 of 7